July 1st 2025
The new building will create 150 new jobs and expands total production area to nearly 12,000 square meters.
DCAT Week 2025: Expanding Sterile Injectables Capacity
March 18th 2025PharmTech Group interviewed Lee Karras of Noramco live on site at DCAT Week 2025, shortly after the company announced a $25 million investment in sterile injectable manufacturing capabilities at its Halo Pharma facility in New Jersey.
DCAT Week 2025: Maintaining Aseptic Integrity and Stability in Sterile Injectable Manufacturing
March 18th 2025Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in the manufacturing of sterile injectable pharmaceuticals.